Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphoid × ofatumumab × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma 3 Leukemia 3 Burkitt Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Autoimmune Diseases of the Nervous System 1 Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1

Interventions

Cyclophosphamide 6 fludarabine phosphate 4 Whole-Body Irradiation 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 fludarabine 3 Mycophenolic Acid 3 Busulfan 3 pirtobrutinib 2 ibrutinib 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bone Marrow Transplantation 2 Biopsy 2 venetoclax 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 duvelisib 1 Thiotepa 1 Social Determinants of Health 1 Sirolimus 1 Receptors, Chimeric Antigen 1 Methotrexate 1 Leukapheresis 1 Immunotherapy, Adoptive 1 Cyclosporins 1 Cyclosporine 1 Azacitidine 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡